- 1
- 2
Mr Seppo Mäkinen
Evergreen Fund, Investment arm of Merieux Institute Group still owned by Merieux Family. In the worldwide group several companies like BioMerieux, Merieux Nutraceuticals, Transgene etc.
Merieux Developpement
Mr Jouni Mäkipää
Smartvisio care- and entertainment service runs on a cloud-based service platform which delivers communication and content services to the customers using standard audiovisual equipment – any standard TV and webcam are totally sufficient.
Mr Tapio Mäntysalo
Ocuspecto develops an automatic visual system measuring device which will revolutionize current screening practices. The invention is based on long term research work done by ophthalmologist and Ocuspecto founder Markku Leinonen who needed a method to study visual fields of small children.
The product Ocusweep is based on innovative, patented technology, which accurately measures eye movements without expensive eye-tracker. Ocusweep is patient-friendly, easy-to-use and affordable system, while making testing error-proof. Nursing staff or opticians are able to execute the tests on behalf of physicians, optometrists or ophthalmologists, saving costs and time to results. Ocusweep is light-weight (5kg) and mobile class I medical device which combines several existing devices into one.
Mr Andres Mellik
Cognuse is developing solutions for the mental healthcare industry.
Our core product platform CognuseManager is an evidence-based patient-centric tool for cognitive rehabilitation in the executive functions domain. It allows TBI and stroke patients to continue their rehabilitation processes in the home setting on most modern devices with a touch screen and gives the therapist an opportunity to monitor their progress in real-time and adjust the training plans, when necessary.
While the initial set of exercises focused on real-life tasks, we are now expanding into other cognitive domains to provide a full suite of services for the rehabilitation flow.
Our customers include hospitals, clinics, independent professionals and home users in neuropsychological rehabilitation, mental healthcare and other related sectors.